Monthly Archives: September 2016

20 September 2016

Xeros: Interim Results

By |September 20th, 2016|

Major progress in developing and commercialising platform technology

Xeros Technology Group plc (AIM: XSG, ‘the Group’, ‘Xeros’), the developer and provider of patented polymer bead systems with multiple commercial applications, publishes its second unaudited interim results for the six months ended 30 June 2016.

Highlights

Platform technology

·      Possess disruptive bead technology platform which can be […]

Horizon Discovery – Strong Revenue Growth and Focus on Operational Gearing Underpin Path to Profitability

By |September 20th, 2016|

Cambridge, UK, 20 September 2016: Horizon Discovery Group plc (LSE: HZD), a world leader in the application of gene editing technologies, announces its interim results for the six months ended 30 June 2016.
Highlights (including post period end):
Financial
·     Group revenue increased 19% to £10.2 million (HY15: £8.6 million)
·     Products business revenue increased 62% to £4.8 […]

Revolymer – Divestment of nicotine gum business

By |September 19th, 2016|

Further to the announcement published on 20 June 2016, Revolymer (AIM: REVO) announces that, on 16 September 2016, it executed agreements committing it to divest its nicotine gum business to the Danish company Alkalon A/S (“Alkalon”), with completion subject only to the satisfaction of certain customary conditions precedent including the transfer of key customer […]

OxfordPV – Parkwalk closes further funding round

By |September 16th, 2016|

We are pleased to announce that Parkwalk has made a further investment in OxfordPV through a the Opportunities EIS Fund.

Oxford Photovoltaics is an Oxford-based technology business, founded in 2010, formed on technology originally developed in the Department of Physics at the University of Oxford under Professor Henry Snaith and his academic team of 20 scientists.

Professor Snaith is […]

Microsaic Systems – Parkwalk Opportunities Fund closes follow on investment

By |September 12th, 2016|

We are delighted to have participated in a placing for Microsaic Systems:
12 September 2016
On 26 August 2016, Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announced a proposed Placing to raise up to £5.4 million (before expenses) through the issue of up to 108,000,000 new ordinary shares of 0.25p each (“New Ordinary Shares”) […]

Healthera – University of Cambridge Enterprise Fund III investment

By |September 1st, 2016|

We are delighted to announce that the University of Cambridge Enterprise Fund III has invested in Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of Cambridge Enterprise Fund III, FT Capital and high net worth individuals. The specific amounts are undisclosed.

This […]